🏅 FDA Orphan Designation
HEMANGEOL
propranolol
Manufacturer: Eton Pharmaceuticals, Inc.
Indicated for:📚 OBSOLETE: Infantile non-syndromic cataract
Indications & Usage
1 INDICATIONS AND USAGE HEMANGEOL oral solution contains the beta-adrenergic blocker propranolol hydrochloride and is indicated for the treatment of proliferating infantile hemangioma requiring systemic therapy. HEMANGEOL oral solution is a beta-adrenergic blocker indicated for the treatment of proliferating infantile hemangioma requiring systemic therapy. ( 1 )
💙 Support Programs
View all →HEMANGEOL
Pierre Fabre
PROPRANOLOL
Unknown
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.